Clinical trials for Cancer in United States

Testing the Addition of Abemaciclib to Olaparib for Women With Recurrent Ovarian Cancer

Study ID: NCT04633239

Sponsor

National Cancer Institute (NCI)

A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

Study ID: NCT06623422

Sponsor

Merck Sharp & Dohme LLC

PET/CT Imaging to Evaluate Cardiac Radiation Damage in Patients With Lung or Esophageal Cancer, EUCLID Trial

Study ID: NCT05775939

Sponsor

Thomas Jefferson University

Training Swallowing Initiation During Expiration

Study ID: NCT05278039

Sponsor

Northwestern University

PAS 1ml Magtrace® for Sentinel Lymph Node Biopsy in Breast Cancer Patients

Study ID: NCT06610539

Sponsor

Endomagnetics Ltd.

Prophylactic Peptide Vaccine in Advanced ALK+ NSCLC

Study ID: NCT05950139

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

A Study of Different Sequences of Cilta-cel, Talquetamab in Combination With Daratumumab and Teclistamab in Combination With Daratumumab Following Induction With Daratumumab, Bortezomib, Lenalidomide and Dexamethasone in Participants With Standard-risk Newly Diagnosed Multiple Myeloma

Study ID: NCT06577025

Sponsor

Janssen Research & Development, LLC

A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Study ID: NCT05128825

Sponsor

K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc

I3LUNG: Integrative Science, Intelligent Data Platform for Individualized LUNG Cancer Care With Immunotherapy

Study ID: NCT05537922

Sponsor

IRCCS Foundation National Cancer Institute, Milan

Educating Smokers About Lung Cancer Screening Using Tobacco Quitlines

Study ID: NCT04595422

Sponsor

M.D. Anderson Cancer Center